a oc fa
J “ye pe Mey
MAR 2 - 2005 a
510(k) Summary of Safety and Effectiveness
kos q 4G
Gyrus PSR System ‘t i
Submitted by: Gyrus Medical Inc.
6655 Wedgwood Road, Suite 105
Maple Grove, MN 55311-3602
Contact Person: Mark Jensen
Vice President RA/QA
Telephone: 763-416-3005
Facsimile: 763-416-3070
Date Summary Prepared: May 5, 2004
Name of the Device:
Proprietary Name: Gyrus Plasma Skin Resurfacing (PSR) System
Common/Usual Name: Electrosurgical Generator and Accessories
Classification Name: Electrosurgical Device (per 21 CFR 878.4400)
Predicate Device: Gyrus Plasma Skin Resurfacing (PSR) System
(K023111)
Description: The Gyrus Medical PSR System is intended for treatment of the following
dermatological conditions:
« Rhytides of the face :
¢ Superficial skin lesions
e Actinic Keratosis
¢ Viral papillomata
* Seborrhoeic Keratosis
Accessories included with the generator are a cable assembly/instrument, power cable
and a footswitch.

Page aD “) (a)

Statement of Intended Use: The Gyrus PSR System is intended for
treatment of dermatological conditions.

This device is intended for use by qualified
medical personne! trained in the use of
electrosurgery.

Comparison to Predicate Device: The Gyrus PSR System has been carefully
compared to legally marketed devices with
respect to intended use and safety and
effectiveness. In addition, clinical studies have
been done to validate the performance of the
device. The clinical data results presented in
this 510(k) notification to the FDA show that the
device is substantially equivalent to legally
marketed devices with respect to intended use
and technological characteristics, and is safe
and effective in its intended use.

peenncts,
i J DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
i Food and Drug Administration
wan 2 - 205 oe
Mr. Mark Jensen
Vice President, RA/QA
Gyrus Medical, Inc.
6655 Wedgwood Road, Suite 105
Maple Grove, Minnesota 55311
Re: K041999
Trade/Device Name: Gyrus Plasma Skin Resurfacing (PSR) System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: I]
Product Code: GEI
Dated: November 22, 2004
Received: November 23, 2004
Dear Mr. Jensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
‘general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class Il (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register. ~
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencics. You must
comply with all the Act’s requirements, including. but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820), and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. Mark Jensen
This letter wil! allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21 CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/edrh/industry/support/index hunt.

Sincerely yours,

Lo ;
qunuene C0 Reveal
octia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

Indications for Use
kKOoGlag9
510(k) Number (if known): K041999 © ————————~*
Device Name: Gyrus PSR System ,
ELECTROSURGICAL GENERATOR
Indications For Use:
The Gyrus Medical PSR System is intended for treatment of the
following dermatological conditions:
e Rhytides of the face
« Superficial skin lesions
e Actinic Keratosis
e Viral papillomata
e Seborrhoeic Keratosis
The system is intended for use by qualified medical personnel
trained in the use of electrosurgical equipment.
Prescription Use__X AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
__ ee
Concurrence of CDRH, Office of Device Evaluation (ODE)
4% :
Yuan C ~ Yrevet Page lof_ i
(Division Sign -: +
Division of Genera. Restore tive.
and Neurologicai Devices
6411979
510(k) Number__/* “7° ''/

